łączymy wszystkie strony biobiznesu


Sympozjum The 13th International Symposium "Molecular basis of pathology and therapy in neurological disorders" i The 4th International Conference "Stem cells: therapeutic outlook for nervous system disorders"
Data rozpoczęcia:
Data zakończenia:
Centrum Medycyny Doświadczalnej i Klinicznej im. Mossakowskiego PAN, Komitet Nauk Neurologicznych PAN oraz Komitet Fizjologii i Nauk Farmakologicznych PAN



On behalf of the Organizing Committee we would like to invite you to our conference which this year will be a joint conference of:


  • The 13th International Symposium "Molecular basis of pathology and therapy in neurological disorders"
  • The 4th International Conference "Stem cells: therapeutic outlook for nervous system disorders",

which will be held in November 17 – 18, 2016 in Warsaw


Our conference will focus on recent advances in research on molecular mechanisms involved in central nervous system functioning in health and disease, as well as implementation of novel experimental therapies to the neurological clinic.

All participants will have the opportunity to attend interesting lectures and present their latest results in poster form. We are looking forward to your enthusiastic interest and participation.

See you in Warsaw!

Organizing Committee







Thursday, November 17, 2016

Molecular basis of pathology and therapy in neurological disorders


9:15 Opening Ceremony

Session I:



Chair: Michal Toborek and Jerzy Lazarewicz
9:30-10:00 Michal Toborek (Miami, FL, USA)
Methamphetamine-induced aberrant neurogenesis in the hippocampus 
10:00-10:30 Leonora Buzanska (Warsaw, Poland)
Micro- and macro-scale approach of stem cell based developmental neurotoxicity 
10:30-11:00 Coffee break
11:00-11:30 Malgorzata Kajta and Wladysław Lason (Krakow, Poland)
Endocrine disruptors and their neurotoxic effects on developing brain
11:30-12:00 Jerzy Lazarewicz (Warsaw, Poland) 
Triggering role of calcium imbalance in the induction of acute oxidative stress and cytotoxicity in primary cultures of rat cerebellar granule cells challenged with TBBP

Lunch and poster session


Session  II:

Glutaminases in the CNS: norm and pathology

Chair: Magdalena Zielinska and Monika Szeliga
13:30-14:00 Jialin Zheng (Nebraska, USA)
Glutaminase, HIV-associated neurocognitive disorders and beyond
14:00-14:30 Manuel Romero Gomez (Sevilla, Spain)
Glutaminase, ammonia and Hepatic Encephalopathy: an opportunity for therapy
14:30-15:00 Inna Gaisler Salomon (Haifa, Israel)
Brain glutaminase in psychiatric disease: from mouse models to schizophrenia
15:00-15:30 Javier Marquez (Malaga, Spain)
Glutamine addiction to brain cancer


Friday, November 18, 2016

Stem Cells: Therapeutic Outlook for Central Nervous System Disorders


9:15 Introduction:  Krystyna Domanska-Janik
President of Cell Therapy Team of the Central Nervous System Diseases, PAS

Session I:

Chair: Wojciech Maksymowicz and Krystyna Domanska-Janik
9:30-10:00 Yang D. Teng (Boston, USA)
Engineered human neural stem cells for treating Spinal Cord Gliomas: 
A Neurobiology-based approach
10:00-10:30 Juan Gallo (Buenos Aires, Argentina)
New strategies of stem cell therapy in retinal disease 
10:30-11:00 Boguslaw Machalinski (Szczecin, Poland)
Hematopoietic stem cell-based therapy in neurodegenerative disorders – cellular and humoral mechanisms
11:00-11:30 Coffe break



Plenary Lecture:

Chair: Leonora Buzanska
11:30-12:30 Anders Bjorklund (Lund, Sweden)
Stem cell therapy for Pakinson`s disease  
12:30-14:00 Lunch and  poster session



Session II: 


Chair:  Boguslaw Machalinski and Yang D. Tang 
14:00-14:30 Wojciech Maksymowicz (Olsztyn, Poland)
Stem cells for ALS: an overview of possible therapeutic approches
14:30-15:00 Marcin Majka (Cracow, Poland)
Stem cells and neurorepair - from bench to clinic and back
15:00-15:30 Anna Sarnowska (Warsaw, Poland)
Pre-transplantation optimization of MSC function for enhancing their regenerative potential
15:30-16.00    Marina A Lynch (Dublin, Ireland)
Modulation of microglial activation by CD200R activation in models of neurodegeneration.
16:00    Closing ceremony




  • Poster presentation will take place on Thursday and Friday at lunch time.
  • Each poster should be no larger than 85 cm x 120 cm. (A0 portrait format).
  • The poster boards will be marked with a number in accord a with the scientific program.
  • Authors are asked to mount their posters before the morning session, and are required to be present with their posters during the assigned presentation time.
  • Please remember to remove your poster at the end of the session.